MannKind Corporation

Healthcare

NASDAQ:MNKD · NASDAQ Global Market

Market Cap $1.22B Beta 1.11 P/E (TTM) -50.3

$3.94 -0.51%

-$0.02 today

52W Low $2.23High $6.51

Vol 11.62M · Avg 5.73M

EPS (TTM) -$0.08Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+3.68%

Period High

$6.21

Period Low

$2.28

Latest

$3.94

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Vera Therapeutics, Inc.

NASDAQ:VERA

$2.49B

Celldex Therapeutics, Inc.

NASDAQ:CLDX

$2.19B

Aurinia Pharmaceuticals Inc.

NASDAQ:AUPH

$2.09B

Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

$1.92B

Nuvation Bio Inc.

NYSE:NUVB

$1.86B

Sionna Therapeutics, Inc.

NASDAQ:SION

$1.67B

AbCellera Biologics Inc.

NASDAQ:ABCL

$1.65B

Immunocore Holdings plc

NASDAQ:IMCR

$1.45B

Biohaven Ltd.

NYSE:BHVN

$1.41B

Janux Therapeutics, Inc.

NASDAQ:JANX

$842.20M

What is the latest MNKD filing?

The latest filing shown is 8-K dated Jun 2, 2026.

How many recent filings does MNKD have?

Intrinsic Alpha currently shows 20 recent filings for MNKD.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.